Latest / Conquer Your Weight / Episode #159: With So Many GLP Options, How Do You Know Which One to Choose?
Transcript
- 0:00Dr. Sarah Stombaugh: This is Dr.
- 0:00Dr. Sarah Stombaugh: Sarah Stombaugh, and you are listening to the Conquer Your Weight Podcast.
- 0:09Announcer: Welcome to the Conquer Your Weight Podcast, where you will learn to understand your mind and body so you can achieve long-term weight loss.
- 0:16Announcer: Here's your host, obesity medicine physician, and life coach, Dr.
- 0:21Announcer: Sarah Stombaugh.
- 0:30Dr. Sarah Stombaugh: And today we are talking about choosing the best GLP medication for you.
- 0:35Dr. Sarah Stombaugh: I am recording this in January of 2026, and this is definitely one of those videos that I'm like, okay, someone's going to watch this in a year or a couple of years even.
- 0:45Dr. Sarah Stombaugh: And like, what is she talking about?
- 0:46Dr. Sarah Stombaugh: There's so many more options, or their prices are totally irrelevant.
- 0:50Dr. Sarah Stombaugh: So it still may be really great information, even if you are listening to this at some point in the distant future.
- 0:56Dr. Sarah Stombaugh: But just be aware that it may not accurately reflect all of the options that are available in the market because it's really exciting.
- 1:02Dr. Sarah Stombaugh: We do have other things coming down the pike, as well as I am going to be talking about prices today, but we've seen a lot of changes when it comes to the prices of these medications.
- 1:11Dr. Sarah Stombaugh: And so those absolutely may not be relevant even like a month or so from now.
- 1:16Dr. Sarah Stombaugh: But let's dive in and talk about all the different options.
- 1:19Dr. Sarah Stombaugh: How do you know which one is the right one for you?
- 1:22Dr. Sarah Stombaugh: Or, you know, what is the best option?
- 1:25Dr. Sarah Stombaugh: And the reality is there are a lot of great options that are out there and it will depend on your individual needs.
- 1:31Dr. Sarah Stombaugh: Now I am going to say during this conversation, there's going to be a lot of demonstrations as I'm holding up different pens and different options and talking through them.
- 1:40Dr. Sarah Stombaugh: So if you are someone who is listening to this on the audio only version, I think I will do a great job of explaining as best that I can.
- 1:48Dr. Sarah Stombaugh: But if you want to check this out on YouTube, that is going to be the best place to see me do the different demonstrations and to see some of those different options available.
- 1:57Dr. Sarah Stombaugh: So today we are going to be talking about all of the medications Ozempic, Wagovi, the Wagovi injection, the Wagovi pill, Zeppound, Manjaro, Sixenda.
- 2:06Dr. Sarah Stombaugh: So let's dive in and talk about these different ones.
- 2:10Dr. Sarah Stombaugh: So as you've probably heard me say or say, heard from other places, these medications, the GLP medications, have been around for a long time.
- 2:19Dr. Sarah Stombaugh: The very first FD-approved medication for the treatment of type 2 diabetes was a medication called Bayetta.
- 2:25Dr. Sarah Stombaugh: It was a twice-a-day injection and it was specifically for type 2 diabetes.
- 2:30Dr. Sarah Stombaugh: It was relatively effective for diabetes, not used as much from a weight perspective.
- 2:36Dr. Sarah Stombaugh: But we've seen as these medications have gotten better, they've gone from twice a day to once a day, now once a week options, at least for the injections.
- 2:44Dr. Sarah Stombaugh: And we've seen how potent and effective these medications have been.
- 2:48Dr. Sarah Stombaugh: They have just taken off in popularity.
- 2:51Dr. Sarah Stombaugh: So let's talk about the different medications that are available.
- 2:54Dr. Sarah Stombaugh: So there are semaglutide medications.
- 2:57Dr. Sarah Stombaugh: Semaglutide is a generic name for the medications that you know is Ozempic and Wagovi.
- 3:02Dr. Sarah Stombaugh: So I do have a Ozempic pen here.
- 3:06Dr. Sarah Stombaugh: And sorry, let me grab it.
- 3:08Dr. Sarah Stombaugh: So the Ozempic pen is semaglutide that is FDA approved for the treatment of type 2 diabetes.
- 3:14Dr. Sarah Stombaugh: It looks like this.
- 3:15Dr. Sarah Stombaugh: It is a multi-dose pen.
- 3:17Dr. Sarah Stombaugh: So every month, someone who had type 2 diabetes was getting this covered by insurance would get a pen that looks like this.
- 3:24Dr. Sarah Stombaugh: It's designed to give four doses of medication.
- 3:27Dr. Sarah Stombaugh: They have to separately get needles that every week, when you're giving an injection, you'd use a new needle.
- 3:32Dr. Sarah Stombaugh: You would dispose of that in a sharps container when you're done.
- 3:35Dr. Sarah Stombaugh: So Ozempic is available for the treatment of type 2 diabetes.
- 3:39Dr. Sarah Stombaugh: And then a couple years later, we saw it available as Wagovi.
- 3:42Dr. Sarah Stombaugh: So this is the Wigovi pen.
- 3:44Dr. Sarah Stombaugh: These are the exact same medication as one another.
- 3:47Dr. Sarah Stombaugh: So Ozempic, Wagovi, exact same medication.
- 3:50Dr. Sarah Stombaugh: Wagovi, when it's given in the injection form as of right now, is available in single pen doses.
- 3:56Dr. Sarah Stombaugh: There are actually multi-dose pens available elsewhere in the world.
- 4:00Dr. Sarah Stombaugh: And so if you're listening outside of the United States, you might be like, why doesn't she know about these multi-dose pens?
- 4:05Dr. Sarah Stombaugh: They're not available in the states as of January 2026.
- 4:09Dr. Sarah Stombaugh: So people who are using Wagovi in the injection form do get these single dose pens.
- 4:14Dr. Sarah Stombaugh: So that looks like every month, when you're getting the prescription, you would get four of these.
- 4:18Dr. Sarah Stombaugh: You would every week inject one.
- 4:20Dr. Sarah Stombaugh: When you're done with it, you would dispose of it in a sharps container.
- 4:23Dr. Sarah Stombaugh: And the next week you would use a new one.
- 4:25Dr. Sarah Stombaugh: And these are the exact same as one another.
- 4:28Dr. Sarah Stombaugh: Ozempic Wagovi, exact same medication.
- 4:31Dr. Sarah Stombaugh: Now, when we think about these two medications, the Wagovi is FD approved for the treatment of weight.
- 4:38Dr. Sarah Stombaugh: But the reality is they're the exact same.
- 4:40Dr. Sarah Stombaugh: So how do we decide between these two?
- 4:42Dr. Sarah Stombaugh: A lot of times it's going to boil down to insurance coverage.
- 4:46Dr. Sarah Stombaugh: If you are someone who has type 2 diabetes, very commonly the GLP medications are covered.
- 4:51Dr. Sarah Stombaugh: That is not always the case.
- 4:53Dr. Sarah Stombaugh: There still be maybe requirements in terms of trialing other medications first, but it is fairly common that there is coverage for type 2 diabetes with the GLP medications.
- 5:03Dr. Sarah Stombaugh: However, for the weight indication, if you have a BMI of 30 or higher, if you have a BMI of 27 or higher with a weight-related comorbidity, that's when we're thinking about using these medications for the treatment of weight.
- 5:16Dr. Sarah Stombaugh: And the coverage of those continues to be spotty.
- 5:19Dr. Sarah Stombaugh: If you're interested in learning more about coverage, we're actually having an entire episode next week where we're talking about the insurance cost, the prior authorization, cash pay, what you can expect in terms of those different options.
- 5:31Dr. Sarah Stombaugh: But not everybody at this time has coverage for medications.
- 5:35Dr. Sarah Stombaugh: At this time, Medicare does not cover these medications at all, although we are anticipating them being covered as soon as April of 2026, which is really exciting.
- 5:44Dr. Sarah Stombaugh: And then we know that right now, insurance companies, commercial insurance, so you get your insurance through the exchange or through your employer, the employers actually opt into or opt out of the treatment of obesity.
- 5:57Dr. Sarah Stombaugh: So even sometimes people who have really good insurance coverage may not have coverage for these medications.
- 6:03Dr. Sarah Stombaugh: So the Wagovi medication can be a really good option, can be very effective.
- 6:08Dr. Sarah Stombaugh: The average person who uses medication has an average weight loss of 15.6% total body weight over the course of about a year in the clinical trials, and people, some of which had more effectiveness, some of people who had less effectiveness, but a really good option.
- 6:23Dr. Sarah Stombaugh: The cash pay prices of these are $199 for the starting doses and $349 for the higher doses of this medication.
- 6:31Dr. Sarah Stombaugh: So it could be a relatively costly thing, but it's a pretty good medication.
- 6:35Dr. Sarah Stombaugh: Now, sometimes, even for a weight perspective, we will use the Ozempic medication.
- 6:41Dr. Sarah Stombaugh: So as you remember, we'll go V, Ozempic, these are the exact same medication, but Ozempic was the one approved for the treatment of type 2 diabetes.
- 6:49Dr. Sarah Stombaugh: Now, as I was telling you, this is designed as a multi-dose pen, meaning that every month when you, or every week rather, when you are going to inject your pen, you there's a little dial here and you'll dial up to your dose of medication and you would dial all the way up and it's going click, click, click, click, click, click, click, and you would dial all the way up.
- 7:08Dr. Sarah Stombaugh: Now, right now it reads 0.5 milligrams.
- 7:11Dr. Sarah Stombaugh: Sorry, it's probably upside down there, reads 0.5 milligrams because this is a demo pen of the starting dose of medication.
- 7:18Dr. Sarah Stombaugh: But one of the really interesting things we can do is actually prescribe a high dose ozembic pen.
- 7:23Dr. Sarah Stombaugh: So someone who is taking a two milligram ozembic pen, if there's four doses of medication in there, then all of a sudden there's eight milligrams of medication in that pen.
- 7:33Dr. Sarah Stombaugh: The cost of an ozembic two milligram pen is $499 per month.
- 7:38Dr. Sarah Stombaugh: So one thing that we can do is we can prescribe that two milligram pen.
- 7:41Dr. Sarah Stombaugh: Again, it has eight milligrams of medication, and then we can have someone do a partial dose of medication.
- 7:46Dr. Sarah Stombaugh: Now, this is definitely something you want to do under the guidance of a physician.
- 7:51Dr. Sarah Stombaugh: But if your physician is willing to prescribe it to you in this way where you take a partial dose of medication, I do actually have a click counting guide on the GLP guide.
- 7:59Dr. Sarah Stombaugh: My online program, the GLP guide, is a great resource for people who are starting out their GLP medication.
- 8:05Dr. Sarah Stombaugh: And especially if you're doing something like this where you're taking a partial dose of the ozempic medication, you want to make sure that you are doing that properly.
- 8:12Dr. Sarah Stombaugh: The amazing thing is, is we can help people to deliver a partial dose of medication.
- 8:17Dr. Sarah Stombaugh: So all of a sudden, a pen that's designed to take, for example, it's going to last for four injections or over the course of about a month, we may be able to help it last quite a bit longer, like two to even eight months.
- 8:29Dr. Sarah Stombaugh: We do want to be careful about the safety of doing that because these medications are not designed to be used for that long of a period of time, but it becomes a very cost-effective option.
- 8:38Dr. Sarah Stombaugh: If you imagine using this over, let's say four months, a $500 pen, all of a sudden, when used over four months, becomes about $125 per month.
- 8:48Dr. Sarah Stombaugh: So even though it sounds pretty expensive at that higher dose, it becomes a really cost-effective option.
- 8:53Dr. Sarah Stombaugh: So we can switch between these medications, Ozempic will go the exact same.
- 8:58Dr. Sarah Stombaugh: We can anticipate very similar weight results from them because they are the same medication.
- 9:02Dr. Sarah Stombaugh: And as with any of these medications, we're starting at the lowest dose and we're titrating up over time to effectiveness.
- 9:09Dr. Sarah Stombaugh: Now, the biggest challenge with these semaglutide medications is that they do have some side effects.
- 9:14Dr. Sarah Stombaugh: All of these medications do, uh predominantly nausea and constipation are the ones that I see come up the most commonly with my patients.
- 9:21Dr. Sarah Stombaugh: I do like to really make sure that we have, especially that constipation piece, well managed before we're titrating up to the next dose.
- 9:28Dr. Sarah Stombaugh: And we're making that decision to move to the next dose when we're seeing that weight loss is not progressing.
- 9:33Dr. Sarah Stombaugh: So we're not seeing the movement on the scale, maybe the effectiveness and the way the medication is feeling in your body, as well as from a side effect standpoint, we want to make sure that those are adequately managed before we move up to the next dose of medication.
- 9:45Dr. Sarah Stombaugh: But either Ozempic or Wagovi, great options, a really good option for many, many people.
- 9:51Dr. Sarah Stombaugh: Now, when we look at the Wigovi pill, I did have a great episode on that last week.
- 9:56Dr. Sarah Stombaugh: If you haven't had a chance to check that out, we talk about all about the Wagovi pill, but that is another great option that was just released earlier this month in January of 2026.
- 10:06Dr. Sarah Stombaugh: And the Wagovi pill is now available as a once daily medication.
- 10:10Dr. Sarah Stombaugh: So if instead of taking an injection, you prefer to take a pill, that is a great option as well.
- 10:15Dr. Sarah Stombaugh: And from a side effect standpoint, from an effectiveness standpoint, it's really pretty similar to the Wagovi injection.
- 10:22Dr. Sarah Stombaugh: So whether we're talking about osempic, wagovi injection, or ragovi pill, those are all very similar options to one another.
- 10:28Dr. Sarah Stombaugh: And we can pretty easily switch between those also if we need to do that.
- 10:32Dr. Sarah Stombaugh: As we move on to other medications, next we're going to be talking about Zeppound.
- 10:36Dr. Sarah Stombaugh: Zeppound at this time is the most potent medication on the market.
- 10:40Dr. Sarah Stombaugh: I don't have a demo pen for the Manjaro here with me right now, but Manjaro and Zeppound are the exact same medication.
- 10:47Dr. Sarah Stombaugh: Manjaro is for the treatment of type 2 diabetes, whereas Zeppound is for the treatment of weight reduction, does have a second indication for the treatment of sleep apnea for moderate or severe sleep apnea.
- 10:58Dr. Sarah Stombaugh: I didn't mention for Ragovi, it also has an indication for cardiovascular disease as well as fatty liver disease.
- 11:04Dr. Sarah Stombaugh: So we do see it used for those indications as well.
- 11:07Dr. Sarah Stombaugh: But these are both the Manjaro and Zeppound, are both terzeptide products.
- 11:12Dr. Sarah Stombaugh: A lot of times they're talked about in the same category of medication as a GLP medication, but the reality is these are GLP slash GIP receptor agonists.
- 11:22Dr. Sarah Stombaugh: So it's targeting two different receptors, the GLP and the GIP receptors.
- 11:26Dr. Sarah Stombaugh: And that can be really good in terms of having more potent effect.
- 11:31Dr. Sarah Stombaugh: The GIP, I like to think of it as further potentiating the effects of the GLP.
- 11:35Dr. Sarah Stombaugh: So people will notice more significant appetite suppression.
- 11:38Dr. Sarah Stombaugh: When we look at the average weight loss over the course of 72 weeks, a little bit longer of a trial, patients on average lost 15% on the lowest weight or on the lowest dose, rather, the 5 milligram treatment dose, they lost 19% on the 10 milligram dose, and they lost 20% on the 15 milligram dose of medication.
- 11:57Dr. Sarah Stombaugh: So certainly more potent of a medication.
- 12:00Dr. Sarah Stombaugh: We also generally see that the side effects of this medication are a little bit better.
- 12:04Dr. Sarah Stombaugh: I commonly see that people may still have nausea, they may still have some of that constipation coming up.
- 12:10Dr. Sarah Stombaugh: Diarrhea is a little bit more frequent on this medication, partially because of the effect of that other receptor, but a lot of people find that their side effects from the Zetbound or Monjaro medication are a little bit less compared to if they were on the semaglutide medications like Ozempic or Rogovi.
- 12:27Dr. Sarah Stombaugh: So honestly, the Zet Bound can be a really great choice because it is so potent and it really is a nice option, both in terms of potency as well as in terms of side effects.
- 12:37Dr. Sarah Stombaugh: At this time, the cost of this is a little bit higher.
- 12:40Dr. Sarah Stombaugh: And if you have insurance coverage, you can be looking at getting the pens.
- 12:44Dr. Sarah Stombaugh: If you don't have insurance coverage, they actually have a vials program.
- 12:47Dr. Sarah Stombaugh: So if you look at this, you will notice that this does say Zetbound on us.
- 12:51Dr. Sarah Stombaugh: So this is brand name Zetbound, similar to the injection.
- 12:55Dr. Sarah Stombaugh: These are the exact same medication, but available in two different forms.
- 12:59Dr. Sarah Stombaugh: So when you're thinking about the cash pay Zetbound option, you're thinking about the Vials program.
- 13:05Dr. Sarah Stombaugh: The cash pay option for that is $299 for the starting dose of 2.5 milligrams, $399 for the five milligram dose, and $449 for the 7.5 milligram dose and higher.
- 13:18Dr. Sarah Stombaugh: So this is a great option as well.
- 13:20Dr. Sarah Stombaugh: While it's not recommended, you could in theory split the doses of medication.
- 13:25Dr. Sarah Stombaugh: So there are people who may take a partial dose of medication, which may make it more cost effective.
- 13:30Dr. Sarah Stombaugh: But especially as we're looking at higher doses of medication, we have to be really careful about that because they do require that you refill every 45 days in order to keep the medication coverage at that 449 or at least to maintain that 449 pricing.
- 13:44Dr. Sarah Stombaugh: But zip-bound medication, great option.
- 13:47Dr. Sarah Stombaugh: If it's covered by insurance, that's a great way to go.
- 13:49Dr. Sarah Stombaugh: And then from a cash pay option, really the most effective option, especially if we're looking at someone, maybe they are looking for a good potency medication.
- 13:58Dr. Sarah Stombaugh: WillGovi is maybe covered or more cost-effective option.
- 14:02Dr. Sarah Stombaugh: So we can start them on Willgovi, bring them up to the top dose over time as they respond to it.
- 14:07Dr. Sarah Stombaugh: And then if we need more potency, we can bring them over to an intermediate dose of Zebound and continue to increase their dose from there.
- 14:14Dr. Sarah Stombaugh: So we think of it as a little bit more potent of a medication.
- 14:17Dr. Sarah Stombaugh: Now, on the other hand, are people who don't need as potent of a medication?
- 14:21Dr. Sarah Stombaugh: You hear a lot of conversations around microdosing, for example.
- 14:25Dr. Sarah Stombaugh: And while microdosing with Ozempic or Zipbound or any of these things may absolutely make sense, my favorite option for people who need less potent effect is actually the Succenda medication.
- 14:38Dr. Sarah Stombaugh: So Sixenda is an oldie but goody.
- 14:40Dr. Sarah Stombaugh: This is a once per day injection, which may turn off some people, but the reality is can be a really great fit for the right person.
- 14:48Dr. Sarah Stombaugh: I will very commonly prescribe this for someone who has a much less significant weight loss goal, maybe much less significant metabolic disease.
- 14:56Dr. Sarah Stombaugh: So especially for the person maybe has perimenopausal weight gain, someone who has a BMI in the upper 20s, so in the range of 25 to 29, this can often be a really good option.
- 15:07Dr. Sarah Stombaugh: It is a once per day option.
- 15:09Dr. Sarah Stombaugh: So that can be, you know, have to get into the routine of doing that every single day.
- 15:12Dr. Sarah Stombaugh: But we also don't see any sort of wearing off effect of this medication.
- 15:16Dr. Sarah Stombaugh: So people really like it for that reason.
- 15:18Dr. Sarah Stombaugh: The lowest dose of this medication is 0.6 milligrams, then it can be titrated all the way up to a three milligram dose.
- 15:25Dr. Sarah Stombaugh: Now, the best part about Sixenda is that even though Sixenda is pretty expensive, it has been available in generic form over the last year.
- 15:34Dr. Sarah Stombaugh: So it took a little bit of time for it to really get going.
- 15:36Dr. Sarah Stombaugh: We've seen it available locally in my market just in the last six months or so.
- 15:40Dr. Sarah Stombaugh: But generic lyric lutide, and I'm talking about not compounded medication, I'm talking about going to your CVS, Walgreens, you know, Costco pharmacy, whatever your local pharmacy is, and getting generic lyri glutide, you can get that over the counter starting at about $80 if you're on the starting dose of medication.
- 15:56Dr. Sarah Stombaugh: So people are able to get this at a pretty cost-effective option.
- 16:00Dr. Sarah Stombaugh: And this is my favorite option for people who may not meet traditional criteria for coverage of the medication.
- 16:06Dr. Sarah Stombaugh: Patients who have early metabolic disease, like I was saying, someone who maybe has 20 or 30 pounds to lose, but does have those signs of elevated blood sugar, maybe elevated cholesterol, elevated liver enzymes, this can be a really excellent medication without being too potent.
- 16:20Dr. Sarah Stombaugh: Now it can still have some side effects, nausea and constipation being the most common, but the side effects are less significant because it is that slightly less potent of a medication.
- 16:30Dr. Sarah Stombaugh: So definitely make sure to consider this as an option, either brand name sucenda or generic luriglutide, excellent option for people with less significant metabolic disease.
- 16:39Dr. Sarah Stombaugh: And lots of things that are coming out.
- 16:41Dr. Sarah Stombaugh: So we've got these four different medications that we're talking about today.
- 16:44Dr. Sarah Stombaugh: That's really exciting to see what's coming down the pike.
- 16:47Dr. Sarah Stombaugh: We know there's going to be another oral GLP on the market likely later this year, a more potent medication called Redatru Time coming on the market end of this year, beginning of next year.
- 16:57Dr. Sarah Stombaugh: So this market is just changing all of the time.
- 17:00Dr. Sarah Stombaugh: If you want to get updates, I want to make sure that you follow me.
- 17:03Dr. Sarah Stombaugh: Like and subscribe if you're following me on YouTube.
- 17:06Dr. Sarah Stombaugh: Share this with someone who would benefit from this information.
- 17:09Dr. Sarah Stombaugh: Thank you for joining me for today's podcast.
- 17:11Dr. Sarah Stombaugh: I'll see you all next week.